United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Use this UTHR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the UTHR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the UTHR SEC filings page. Lician reads the product cache first so this HTML stays unique to United Therapeutics Corporation even when a live quote feed is slow.
Latest cached year on this hub. Full UTHR income, balance, and cash tables.